These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2837353)
1. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies. Hasholt L; Wandall A; Sørensen SA Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353 [TBL] [Abstract][Full Text] [Related]
2. ConA-mediated binding and uptake of purified alpha-galactosidase A in Fabry fibroblasts. Hasholt L; Sørensen SA Exp Cell Res; 1983 Oct; 148(2):405-11. PubMed ID: 6313412 [TBL] [Abstract][Full Text] [Related]
3. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement. Sifers RN; Mayes JS; Nordquist RE Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565 [TBL] [Abstract][Full Text] [Related]
4. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease. Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697 [TBL] [Abstract][Full Text] [Related]
5. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes. Wandall A; Hasholt L; Sørensen SA Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349 [TBL] [Abstract][Full Text] [Related]
6. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Mayes JS; Scheerer JB; Sifers RN; Donaldson ML Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Human Dermal Fibroblasts in Fabry Disease. Lakomá J; Donadio V; Liguori R; Caprini M J Cell Physiol; 2016 Jan; 231(1):192-203. PubMed ID: 26058984 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins. Hasholt L; Sørensen SA Hum Genet; 1986 Jan; 72(1):72-6. PubMed ID: 3002954 [TBL] [Abstract][Full Text] [Related]
10. Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease. Chiba Y; Sakuraba H; Kotani M; Kase R; Kobayashi K; Takeuchi M; Ogasawara S; Maruyama Y; Nakajima T; Takaoka Y; Jigami Y Glycobiology; 2002 Dec; 12(12):821-8. PubMed ID: 12499404 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes. Fensom AH; Benson PF; Grant AR; Jacobs L J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649 [TBL] [Abstract][Full Text] [Related]
13. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote. Osada T; Kuroda Y; Ikai A Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells. Johnson DL; Desnick RJ Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178 [No Abstract] [Full Text] [Related]
15. Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice. Meng XL; Day TS; McNeill N; Ashcraft P; Frischmuth T; Cheng SH; Liu ZP; Shen JS; Schiffmann R J Inherit Metab Dis; 2016 May; 39(3):447-455. PubMed ID: 26960552 [TBL] [Abstract][Full Text] [Related]
16. A case of Fabry's disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser. Koide T; Ishiura M; Iwai K; Inoue M; Kaneda Y; Okada Y; Uchida T FEBS Lett; 1990 Jan; 259(2):353-6. PubMed ID: 2152885 [TBL] [Abstract][Full Text] [Related]
17. Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase-deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease. Inagaki M; Katsumoto T; Nanba E; Ohno K; Suehiro S; Takeshita K Acta Neuropathol; 1993; 85(3):272-9. PubMed ID: 8384772 [TBL] [Abstract][Full Text] [Related]
18. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients. Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201 [TBL] [Abstract][Full Text] [Related]
19. A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations. Hasholt L; Sørensen SA; Wandall A; Andersen EB; Arlien-Søborg P J Med Genet; 1990 May; 27(5):303-6. PubMed ID: 2161929 [TBL] [Abstract][Full Text] [Related]
20. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote. Osada T; Kuroda Y; Ikai A Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]